Implementation of a Prehospital Stroke Triage System Using Symptom Severity and Teleconsultation in the Stockholm Stroke Triage Study.
Journal
JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536
Informations de publication
Date de publication:
01 06 2020
01 06 2020
Historique:
pubmed:
7
4
2020
medline:
18
2
2021
entrez:
7
4
2020
Statut:
ppublish
Résumé
To our knowledge, it is unknown whether a prehospital stroke triage system combining symptom severity and teleconsultation could accurately select patients for primary stroke center bypass and hasten delivery of endovascular thrombectomy (EVT) without delaying intravenous thrombolysis (IVT). To evaluate the predictive performance of the newly implemented Stockholm Stroke Triage System (SSTS) for large-artery occlusion (LAO) stroke and EVT initiation. Secondary objectives included evaluating whether the Stockholm Stroke Triage System shortened onset-to-puncture time for EVT and onset-to-needle time (ONT) for IVT. This population-based prospective cohort study conducted from October 2017 to October 2018 across the Stockholm region (Sweden) included patients transported by first-priority ("code stroke") ambulance to the hospital for acute stroke suspected by an ambulance nurse and historical controls (October 2016-October 2017). Exclusion criteria were in-hospital stroke and helicopter or private transport. Of 2909 eligible patients, 4 (0.14%) declined participation. Patients were assessed by ambulance nurses with positive the face-arm-speech-time test or other stroke suspicion and were evaluated for moderate-to-severe hemiparesis (≥2 National Institutes of Health stroke scale points each on the ipsilateral arm and leg [A2L2 test]). If present, the comprehensive stroke center (CSC) stroke physician was teleconsulted by phone for confirmation of stroke suspicion, assessment of EVT eligibility, and direction to CSC or the nearest primary stroke center. If absent, the nearest hospital was prenotified. Primary outcome: LAO stroke. Secondary outcomes: EVT initiation, onset-to-puncture time, and ONT. Predictive performance measures included sensitivity, specificity, positive and negative predictive values, the overall accuracy for LAO stroke, and EVT initiation. We recorded 2905 patients with code-stroke transports (1420 women [49%]), and of these, 323 (11%) had A2L2+ teleconsultation positive results and were triaged for direct transport to CSC (median age, 73 years [interquartile range (IQR), 64-82 years]; 55 women [48%]). Accuracy for LAO stroke was 87% (positive predictive value, 41%; negative predictive value, 93%) and 91% for EVT initiation (positive predictive value, 26%; negative predictive value, 99%). Endovascular thrombectomy was performed for 84 of 323 patients (26%) with triage-positive results and 35 of 2582 patients (1.4%) with triage-negative results. In EVT cases with a known onset time (77 [3%]), the median OPT was 137 minutes (IQR, 118-180; previous year, 206 minutes [IQR, 160-280]; n = 75) (P < .001). The regional median ONT (337 [12%]) was unchanged at 115 minutes (IQR, 83-164; previous year, 115 minutes [IQR, 85-161]; n = 360) (P = .79). The median CSC IVT door-to-needle time was 13 minutes (IQR, 10-18; 116 [4%]) (previous year, 31 minutes [IQR, 19-38]; n = 45) (P < .001). The Stockholm Stroke Triage System, which combines symptom severity and teleconsultation, results in markedly faster EVT delivery without delaying IVT.
Identifiants
pubmed: 32250423
pii: 2763539
doi: 10.1001/jamaneurol.2020.0319
pmc: PMC7136864
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
691-699Commentaires et corrections
Type : CommentIn
Références
JAMA Neurol. 2018 Dec 1;75(12):1467-1469
pubmed: 30193286
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
JAMA Neurol. 2019 Sep 3;:
pubmed: 31479116
Int J Stroke. 2015 Aug;10(6):822-9
pubmed: 25588617
Stroke. 2017 Aug;48(8):2164-2170
pubmed: 28701576
Int J Stroke. 2018 Apr;13(3):321-327
pubmed: 28612680
Stroke Vasc Neurol. 2018 Sep 3;3(4):215-221
pubmed: 30637127
Lancet Neurol. 2017 Mar;16(3):227-237
pubmed: 28229894
J Neurointerv Surg. 2019 Aug;11(8):751-756
pubmed: 30580284
Stroke. 2005 Oct;36(10):2121-5
pubmed: 16151026
Br Med J. 1961 Feb 4;1(5222):309-14
pubmed: 13681380
Stroke. 1989 Jul;20(7):864-70
pubmed: 2749846
J Neurointerv Surg. 2018 Oct;10(10):932-936
pubmed: 29436505
J Neurol. 2016 Aug;263(8):1633-40
pubmed: 27272907
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Stroke. 2012 Oct;43(10):2666-70
pubmed: 22879096
BMJ. 2015 Oct 28;351:h5527
pubmed: 26511519
Stroke. 2013 Apr;44(4):1153-7
pubmed: 23471266
Lancet. 2014 Nov 29;384(9958):1929-35
pubmed: 25106063
J Neurointerv Surg. 2020 Mar;12(3):233-239
pubmed: 31484698
Neuroradiology. 2014 Jun;56(6):477-86
pubmed: 24687568
Circulation. 2017 Dec 12;136(24):2311-2321
pubmed: 28943516
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
JAMA. 2016 Sep 27;316(12):1279-88
pubmed: 27673305
Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1):
pubmed: 28096207
Expert Rev Cardiovasc Ther. 2019 Jan;17(1):3-9
pubmed: 30451541
J Neurointerv Surg. 2016 Aug;8(8):775-7
pubmed: 26276076
Stroke. 2018 Apr;49(4):945-951
pubmed: 29540611
J Vasc Interv Radiol. 2019 Oct;30(10):1714-1716
pubmed: 31547930
JAMA Neurol. 2019 Apr 1;76(4):405-411
pubmed: 30667465
J Neurointerv Surg. 2017 Jul;9(7):631-635
pubmed: 27342763
Neurology. 2012 Jul 24;79(4):306-13
pubmed: 22622858
Ther Adv Neurol Disord. 2016 Mar;9(2):79-84
pubmed: 27006695